JPH11512703A5 - - Google Patents

Info

Publication number
JPH11512703A5
JPH11512703A5 JP1997513154A JP51315497A JPH11512703A5 JP H11512703 A5 JPH11512703 A5 JP H11512703A5 JP 1997513154 A JP1997513154 A JP 1997513154A JP 51315497 A JP51315497 A JP 51315497A JP H11512703 A5 JPH11512703 A5 JP H11512703A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997513154A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11512703A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1996/004261 external-priority patent/WO1997011680A2/en
Publication of JPH11512703A publication Critical patent/JPH11512703A/ja
Publication of JPH11512703A5 publication Critical patent/JPH11512703A5/ja
Ceased legal-status Critical Current

Links

JP9513154A 1995-09-28 1996-09-30 ホルモン置換療法およびホルモンディスペンサー Ceased JPH11512703A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53540295A 1995-09-28 1995-09-28
US08/535,402 1995-09-28
PCT/EP1996/004261 WO1997011680A2 (en) 1995-09-28 1996-09-30 Hormone replacement therapy method and hormone dispenser

Publications (2)

Publication Number Publication Date
JPH11512703A JPH11512703A (ja) 1999-11-02
JPH11512703A5 true JPH11512703A5 (OSRAM) 2004-09-30

Family

ID=24134029

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9513154A Ceased JPH11512703A (ja) 1995-09-28 1996-09-30 ホルモン置換療法およびホルモンディスペンサー

Country Status (23)

Country Link
US (2) US5922349A (OSRAM)
EP (1) EP0854705B1 (OSRAM)
JP (1) JPH11512703A (OSRAM)
KR (1) KR20000004898A (OSRAM)
CN (1) CN1158206C (OSRAM)
AT (1) ATE255406T1 (OSRAM)
AU (1) AU714084B2 (OSRAM)
BR (1) BR9610915A (OSRAM)
CA (1) CA2232621A1 (OSRAM)
CZ (1) CZ95598A3 (OSRAM)
DE (1) DE69630968T2 (OSRAM)
DK (1) DK0854705T3 (OSRAM)
ES (1) ES2211983T3 (OSRAM)
HU (1) HUP9802608A3 (OSRAM)
IL (1) IL123691A (OSRAM)
MX (1) MX9802370A (OSRAM)
NO (1) NO320491B1 (OSRAM)
PL (1) PL185848B1 (OSRAM)
PT (1) PT854705E (OSRAM)
TR (1) TR199800560T1 (OSRAM)
TW (1) TW329389B (OSRAM)
WO (1) WO1997011680A2 (OSRAM)
ZA (1) ZA968227B (OSRAM)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6551611B2 (en) * 1995-09-28 2003-04-22 Schering Aktiengesellschaft Hormone replacement therapy method
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
CN1133422C (zh) * 1997-07-08 2004-01-07 科斯莫弗姆有限公司 过氧化苯甲酰和第二种活性成分的组合的局部用药
CA2267743C (en) 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
AU2005201151B2 (en) * 1999-03-30 2008-01-10 Jencap Research Ltd Low dose estrogen interrupted hormone replacement therapy
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP2305267A3 (en) * 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
SI1214076T1 (en) * 1999-08-31 2004-06-30 Schering Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US20040191276A1 (en) * 1999-11-30 2004-09-30 Cutispharma, Inc. Compositions and kits for compounding pharmaceuticals
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
JP5128743B2 (ja) * 2000-01-18 2013-01-23 バイエル ファーマ アクチエンゲゼルシャフト ホルモン置換療法用のドロスピレノン
IL149990A0 (en) * 2000-01-28 2002-12-01 Endorech Inc Selective estrogen receptor modulators in combination with estrogens
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
NZ524423A (en) * 2000-08-03 2004-04-30 Antares Pharma Ipl Ag A composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US20040172169A1 (en) * 2001-03-02 2004-09-02 Curtis Wright Method and apparatus for compouding individualized dosege forms
AU2002240949A1 (en) * 2001-03-21 2002-10-03 Schering Aktiengesellschaft Pharmaceutical combined preparations containing aromatase inhibitors and substances having an estrogen effect in addition to the use thereof for producing a medicament for estrogen-replacement-therapy
US7455656B2 (en) * 2001-07-26 2008-11-25 Langeler Gerard E Pill delivery system
WO2003082299A1 (en) * 2002-04-03 2003-10-09 Jencap Research Ltd. Improved hormone replacement therapy
IL164808A0 (en) * 2002-04-26 2005-12-18 Schering Ag Treatment of hypertesion in women receiving hormone replacement therapy
US20040062794A1 (en) * 2002-09-30 2004-04-01 Lee Shulman 17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
US7786101B2 (en) * 2002-11-05 2010-08-31 Bayer Schering Pharma Ag Cardiovascular protection using anti-aldosteronic progestins
US6669390B1 (en) * 2002-11-22 2003-12-30 John J. Porter Breath freshener with mouthwash atomizer
US7354598B2 (en) 2002-12-20 2008-04-08 Kimberly-Clark Worldwide, Inc. Packaging two different substrates
US7858607B2 (en) * 2003-03-14 2010-12-28 Mamchur Stephen A System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
US7785584B2 (en) * 2003-08-13 2010-08-31 Healthpoint, Ltd. Ointment wound spray
JP5619337B2 (ja) 2003-10-10 2014-11-05 フェリング ビー.ブイ. 皮膚残渣を最小限に抑えるための経皮的医薬製剤
US7293738B2 (en) * 2003-11-26 2007-11-13 Kimberly-Clark Worldwide, Inc. Freestanding dispenser for dispensing two different substrates
US20050222106A1 (en) * 2004-04-01 2005-10-06 Stefan Bracht Drospirenone-containing preparations for transdermal use
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
WO2006125642A1 (en) * 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US7537139B2 (en) * 2005-05-27 2009-05-26 Henkel Corporation Dual chamber piston pressure pack dispenser system
US20090181075A1 (en) * 2005-07-15 2009-07-16 Gordon Ryan D Drospirenone containing transdermal drug delivery devices and methods of delivery thereof
EP1971325A2 (en) * 2005-12-27 2008-09-24 Duramed Pharmaceuticals, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
NZ571460A (en) 2006-04-21 2010-10-29 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
US7476291B2 (en) * 2006-09-28 2009-01-13 Lam Research Corporation High chamber temperature process and chamber design for photo-resist stripping and post-metal etch passivation
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
US9795617B2 (en) 2009-06-18 2017-10-24 Baucom Institute for Longevity and Life Enhancement, Inc. Hormone delivery system and method
US8658628B2 (en) * 2009-06-18 2014-02-25 Karan Y. Baucom Hormone delivery system and method
BR112013028171A2 (pt) 2011-05-02 2020-05-12 Mouse Trap Design, Llc Dispositivo para misturar uma pluralidade de fluidos para formular uma mistura e para dispensar a mistura
CA2745320A1 (en) * 2011-07-06 2013-01-06 Duoject Medical Systems Inc. Reconstitution device
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150122837A1 (en) 2013-11-07 2015-05-07 Mouse Trap Design, Llc Mixing and dispensing device
WO2015179782A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3156349B1 (en) * 2015-10-16 2018-07-04 Fontem Holdings 1 B.V. Mixing bottle
US10184818B2 (en) 2015-11-12 2019-01-22 Nodari Rizun Device and method for dispensing paste-like or sticky nutritional substance
US9903747B2 (en) * 2015-11-12 2018-02-27 Nodari Rizun Device and method for dispersing paste-like or sticky nutritional substance in a fluid
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CN108310608B (zh) * 2018-02-02 2020-07-31 韩明辉 一种医疗康复护理用涂药器
US10285998B1 (en) 2018-04-04 2019-05-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US11382400B2 (en) 2018-08-10 2022-07-12 Go Products Co. Material applicator
WO2020030975A2 (en) * 2018-08-10 2020-02-13 Azura Ophthalmics Ltd. Dispenser for precise extraction of a semi-solid product
CN111038860A (zh) * 2018-10-12 2020-04-21 元盛生医电子股份有限公司 容器结构
JP7315727B2 (ja) * 2019-07-09 2023-07-26 ザ プロクター アンド ギャンブル カンパニー 多組成物製品ディスペンサ
CN115279458A (zh) 2020-01-10 2022-11-01 阿祖拉眼科有限公司 组合物和敏感性说明
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1586771A (en) * 1976-10-22 1981-03-25 Plessey Co Ltd Taximeter
DE2927584A1 (de) * 1979-07-07 1981-01-22 Henkel Kgaa Vorrichtung zum dosieren von zweikomponenten-produkten
FR2525183A2 (fr) * 1982-04-19 1983-10-21 Fabre Sa Pierre Dispositif de distribution en proportion reglable de deux substances pateuses
US4871092A (en) * 1982-07-10 1989-10-03 Ing. Erich Pfeiffer Gmbh & Co. Kg Atomizing or metering pump
US4687663B1 (en) * 1983-03-01 1997-10-07 Chesebrough Ponds Usa Co Dental preparation article and method for storage and delivery thereof
US4705783A (en) * 1985-06-25 1987-11-10 Sri International 9α, 11β-substituted and 11β-substituted estranes
DE3614515A1 (de) * 1986-04-29 1987-11-05 Pfeiffer Erich Gmbh & Co Kg Austragvorrichtung fuer medien
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
US4906169A (en) * 1986-12-29 1990-03-06 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US5422119A (en) * 1987-09-24 1995-06-06 Jencap Research Ltd. Transdermal hormone replacement therapy
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US4838457A (en) * 1988-05-09 1989-06-13 Swahl James C Lotion blending and dispensing unit
US5020694A (en) * 1989-03-16 1991-06-04 Chesebrough-Pond's, Inc. Multi-cavity dispensing container
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
FR2652567B1 (fr) * 1989-10-04 1992-01-10 Oreal Dispositif de distribution comportant au moins un flacon a embout cassable.
US5116865A (en) * 1990-09-05 1992-05-26 Peters Richard H 15,16-seco-19-nor progestins
US5286258A (en) * 1991-03-08 1994-02-15 Habley Medical Technology Corporation Multipharmaceutical delivery system
US5240146A (en) * 1990-12-14 1993-08-31 Smedley William H Variable proportion dispenser
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5339990A (en) * 1992-11-10 1994-08-23 Wilder Robert E Adjustable pump dispenser
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy

Similar Documents

Publication Publication Date Title
JP2000500228A5 (OSRAM)
JP2000500033A5 (OSRAM)
JP2000500445A5 (OSRAM)
JP2000500440A5 (OSRAM)
JP2000500327A5 (OSRAM)
JP2000500145A5 (OSRAM)
JPH11512703A5 (OSRAM)
JP2000500155A5 (OSRAM)
JP2000500406A5 (OSRAM)
JP2000500361A5 (OSRAM)
JP2000500115A5 (OSRAM)
JP2000500322A5 (OSRAM)
JP2000500258A5 (OSRAM)
JP2000500342A5 (OSRAM)
JP2000501986A5 (OSRAM)
JP2000500192A5 (OSRAM)
JP2000500112A5 (OSRAM)
JP2000500226A5 (OSRAM)
JP2000500051A5 (OSRAM)
JP2000500407A5 (OSRAM)
JP2000500397A5 (OSRAM)
JP2000500166A5 (OSRAM)
JP2000500125A5 (OSRAM)
JP2000500346A5 (OSRAM)
JP2000500044A5 (OSRAM)